The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2.Cardiol Rev. 2020 Sep/Oct; 28(5):217-218.CR
Links
MeSH
Pub Type(s)
Editorial
Comment
Language
eng
PubMed ID
32639241
Citation
Frishman, William H.. "The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2." Cardiology in Review, vol. 28, no. 5, 2020, pp. 217-218.
Frishman WH. The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2. Cardiol Rev. 2020;28(5):217-218.
Frishman, W. H. (2020). The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2. Cardiology in Review, 28(5), 217-218. https://doi.org/10.1097/CRD.0000000000000328
Frishman WH. The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2. Cardiol Rev. 2020 Sep/Oct;28(5):217-218. PubMed PMID: 32639241.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2.
A1 - Frishman,William H,
PY - 2020/7/9/pubmed
PY - 2020/8/25/medline
PY - 2020/7/9/entrez
SP - 217
EP - 218
JF - Cardiology in review
JO - Cardiol Rev
VL - 28
IS - 5
SN - 1538-4683
UR - https://www.unboundmedicine.com/medline/citation/32639241/The_11th_Trial_of_a_Cardiovascular_Clinical_Trialist:_Coronavirus_2:_Part_2_
DB - PRIME
DP - Unbound Medicine
ER -
